8-KLeadership ChangesRegulation FDExhibits & Filings

EMERSON ELECTRIC CO 8-K Report, Executive Changes (Feb 1, 2021)

Filed February 1, 2021For Securities:EMR

Summary

Emerson Electric Co. (EMR) announced a significant leadership transition in an 8-K filing on February 1, 2021. Effective February 5, 2021, David N. Farr will retire as Chief Executive Officer. Mr. Farr has agreed to continue serving as a Director and non-executive Chairman of the Board until May 4, 2021, ensuring a smooth handover. Concurrently, the company appointed Surendralal (Lal) L. Karsanbhai as the new Chief Executive Officer and elected him as a Director, also effective February 5, 2021. Mr. Karsanbhai, who has been with Emerson in various leadership roles since 2014, most recently as Executive President of Automation Solutions, brings extensive experience to the CEO position. This leadership change marks the end of an era under Mr. Farr's long tenure and the beginning of a new chapter with Mr. Karsanbhai at the helm. The filing also includes a press release detailing these changes and provides standard forward-looking cautionary statements related to business risks and uncertainties, including the ongoing impact of the COVID-19 pandemic. Investors should note the continuity provided by Mr. Farr's extended role as non-executive Chairman and the internal promotion of Mr. Karsanbhai, suggesting a strategic focus on maintaining operational stability during this transition.

Key Highlights

  • 1David N. Farr is retiring as CEO of Emerson Electric Co. effective February 5, 2021.
  • 2Mr. Farr will remain a Director and transition to non-executive Chairman of the Board through May 4, 2021.
  • 3Surendralal (Lal) L. Karsanbhai has been appointed as the new CEO and elected as a Director, effective February 5, 2021.
  • 4Mr. Karsanbhai was previously Executive President of Automation Solutions since October 2018.
  • 5The company issued a press release on February 1, 2021, announcing these leadership changes.
  • 6The filing includes standard forward-looking statements and cautionary disclosures regarding business risks, including the COVID-19 pandemic.

Frequently Asked Questions